Arcadia Biosciences Stock Alpha and Beta Analysis

RKDA Stock  USD 2.74  0.15  5.79%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Arcadia Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Arcadia Biosciences over a specified time horizon. Remember, high Arcadia Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Arcadia Biosciences' market risk premium analysis include:
Beta
2.7
Alpha
(0.14)
Risk
6.86
Sharpe Ratio
0.009
Expected Return
0.0616
Please note that although Arcadia Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Arcadia Biosciences did 0.14  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Arcadia Biosciences stock's relative risk over its benchmark. Arcadia Biosciences has a beta of 2.70  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arcadia Biosciences will likely underperform. At present, Arcadia Biosciences' Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 0.32, whereas Book Value Per Share is forecasted to decline to 9.76.

Enterprise Value

(1.56 Million)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Arcadia Biosciences Backtesting, Arcadia Biosciences Valuation, Arcadia Biosciences Correlation, Arcadia Biosciences Hype Analysis, Arcadia Biosciences Volatility, Arcadia Biosciences History and analyze Arcadia Biosciences Performance.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.

Arcadia Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Arcadia Biosciences market risk premium is the additional return an investor will receive from holding Arcadia Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arcadia Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Arcadia Biosciences' performance over market.
α-0.14   β2.70

Arcadia Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Arcadia Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Arcadia Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Arcadia Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Arcadia Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcadia Biosciences shares will generate the highest return on investment. By understating and applying Arcadia Biosciences stock market price indicators, traders can identify Arcadia Biosciences position entry and exit signals to maximize returns.

Arcadia Biosciences Return and Market Media

The median price of Arcadia Biosciences for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 2.89 with a coefficient of variation of 19.06. The daily time series for the period is distributed with a sample standard deviation of 0.61, arithmetic mean of 3.22, and mean deviation of 0.52. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Rivus Pharmaceuticals Strengthens Executive Team and Board with Appointments of Tom ONeil as Chief Financial Officer and Erin Lavelle as Director
09/11/2024
2
Arcadia Biosciences Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call
10/29/2024
3
Arcadia Biosciences Inc Q3 2024 Earnings Report Preview What To Look For
11/07/2024
4
Arcadia Biosciences Announces Strong Third Quarter 2024 Financial Results and Business Highlights
11/12/2024
5
Earnings call Arcadia Biosciences posts 18 percent revenue jump in Q3
11/13/2024
6
Arcadia Biosciences Q3 Earnings Miss Estimates, Sales Increase YY - MSN
11/21/2024

About Arcadia Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Arcadia or other stocks. Alpha measures the amount that position in Arcadia Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield0.0020420.001815
Price To Sales Ratio0.730.69

Arcadia Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Arcadia Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arcadia Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Arcadia Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Arcadia Biosciences. Please utilize our Beneish M Score to check the likelihood of Arcadia Biosciences' management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Arcadia Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Arcadia Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Arcadia Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Arcadia Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...